- GLP-1 analogues in therapy of obese adolescents. Early real-life experience with liraglutide treatment2023 | Second Faculty of Medicine
- Liraglutid; analog GLP-12011 | Second Faculty of Medicine
- Ovlivnění kardiovaskulárního rizika perorálními antidiabetiky2019 | First Faculty of Medicine
- Fixed combination of long-acting insulin with GLP-1 analogue as an option of treatment intensification in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine
- Co nového přinášejí guidelines ESC 2019 o diabetu, prediabetu a kardiovaskulárních onemocněních2020 | First Faculty of Medicine
- Novinky v diabetologii leden až duben 20222022 | First Faculty of Medicine
- The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters2010 | First Faculty of Medicine
- Exenatid ER v kombinované léčbě diabetes mellitus 2. typu2017 | First Faculty of Medicine
- Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus2008 | Second Faculty of Medicine
- Incretin hormones and the role of incretin mimetics in the treatment of type 2 diabetes mellitus2006 | Second Faculty of Medicine
- Dalaglutid: průlom v injekční léčbě pacientů s diabetem2018 | Publication without faculty affiliation
- Oral antidiabetic drugs in treatment of type 1 diabetes mellitus2016 | Third Faculty of Medicine, Second Faculty of Medicine
- Liraglutide2009 | Second Faculty of Medicine
- Knowledge about GLP-1 based therapies changed the possibilities of diabetes treatment, but its use could be much broader2011 | Third Faculty of Medicine
- Incretin strategy in the treatment of type 2 diabetes mellitus - DPPIV2007 | Second Faculty of Medicine
- Physiological secretion of GLP-1 (glucagon-like peptide-1)2015 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Exenatide2008 | Second Faculty of Medicine
- Dulaglutid2016 | Second Faculty of Medicine